All
Advances in pediatric dermatitis
October 18th 2008Las Vegas - Kawasaki disease (KD), also called mucocutaneous lymph node syndrome, is the most common cause of acquired cardiac disease in children, and it is important to understand its pathogenesis in order to diagnose and treat the child, says Sheila Fallon Friedlander, M.D., clinical professor, pediatrics and medicine, University of California San Diego Medical Center, Rady Children?s Hospital, San Diego.
New developments in atopic dermatitis
October 18th 2008Las Vegas - "TIMS (topical immune modulators) are safer than topical steroids if you don?t feed them heavily to monkeys," says Lawrence A. Schachner, M.D., chairman and Harvey Blank Professor of Dermatology, professor of pediatrics, and director, division of pediatric dermatology, Leonard M. Miller School of Medicine, University of Miami, Miami, Fla.
Tacrolimus ointment effective for pediatric AD, studies show
October 7th 2008Data from two large, phase 4 trials indicate that long-term, intermittent, once-daily therapy with tacrolimus ointment is an effective treatment for pediatric patients with stabilized atopic dermatitis, Docguide.com reports.
Study suggest effectiveness of efalizumab in treating scalp psoriasis
October 7th 2008Results of a recent study show that 68 percent of patients with moderate to severe plaque psoriasis experienced improvement in scalp psoriasis within the first 12 weeks of treatment with efalizumab, Docguide.com reports.
Keraderm to introduce first phototherapy treatment for onychomycosis
October 7th 2008Keraderm, which develops phototherapy treatments for infections, has announced it will introduce a $100 phototherapy treatment for onychomycosis in 2009, upon completion of current pivotal trials and pending marketing clearance from the Food and Drug Administration (FDA), PRNewswire reports.
Reducing the risk: Fighting the incidence of non-melanoma skin cancers with retinoids
October 1st 2008The development of non-melanoma skin cancer is a common sequela of the high doses of immunosuppressive medications that organ transplant recipients receive. A recent study shows that low-dose systemic retinoids can significantly decrease these patients' susceptibility to develop skin cancers (such as squamous cell carcinoma) in the long term.
Stimulating theory: Combination of exercise, caffeine may prove useful in fighting skin cancers
October 1st 2008A recent study shows that a daily low-to-moderate dose of caffeine and regular exercise may very well prevent skin cancers before they occur, in part by promoting the death of sunlight-damaged precancerous cells.
Managing skin cancer: New treatment modalities may soon be available for clinical use
October 1st 2008Gene, molecular and cell-targeted therapies are under investigation for the treatment and prevention of nonmelanoma skin cancers, and some of these modalities may be available for clinical use soon. Recent and forthcoming advances in imaging are also enhancing tumor visualization and surgical planning.
On the rise: Aggressive skin cancers can be easily overlooked
October 1st 2008An expert says dermatologists must be careful not to overlook or misdiagnose four aggressive skin cancers whose incidence rates are rising - lentigo maligna, atypical fibroxanthoma, Merkel cell carcinoma and high-risk squamous cell carcinoma.